Purchase of human induced pluripotent stem cell-derived (hipsc) cells

Active Awarded Last action

Contract number
75F40126F19002
Awardee
Awarding agency
Obligated
$15,133

Award facts

Contract value 100% obligated
$15,133.00 Current and potential, with all options
Completion date 39% complete
Current and potential, with all options
NAICS code
325414 Biological Product (except Diagnostic) Manufacturing
PSC
B529 Special Studies/Analysis- Scientific Data
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Firm Fixed Price
Place of performance
Silver Spring, MD 20903, USA

Award details come from SAM.gov/FPDS.

About this award

The Food and Drug Administration issued a $15,133 delivery order to Fujifilm Biosciences Inc. on June 1, 2026, for the purchase of human induced pluripotent stem cell-derived (hiPSC) cells.

This order is issued under the FDA's single-award Indefinite Delivery Contract with Fujifilm, valued at $500,000 and running through August 31, 2031, which supports procurement of hiPSC cells and related research materials. Place of performance is Silver Spring, Maryland. Performance is scheduled to conclude on May 31, 2027. The order is priced on a firm fixed-price basis with no set-aside applied.

Quick answers

Who was awarded contract 75F40126F19002?

75F40126F19002 was awarded to Fujifilm Biosciences Inc. by Food and Drug Administration (Department of Health and Human Services) on June 1, 2026.

How much is contract 75F40126F19002 worth?

The government has obligated $15,133 on 75F40126F19002.

Is contract 75F40126F19002 an order under another contract?

Yes. 75F40126F19002 is a delivery order under 75F40125D00013, an indefinite delivery contract.

Was contract 75F40126F19002 competed?

The extent of competition for 75F40126F19002 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award